Showing results (401-410 of 618) with videos related to
Sort By:
Pageof 62
Revue Medicale De Liege|February 5, 2021
[Anticoagulation of diabetic patients with nonvalvular atrial fibrillation]A J Scheen, M Sprynger, P LancellottiRevue Medicale De Liege|December 22, 1999
[Arterial hypertension and type 2 diabetes]A J Scheen, F Estrella, L WeekersRevue Medicale De Liege|September 23, 2010
[Liraglutide (Victoza): human glucagon-like peptide-1 used in once daily injection for the treatment of type 2 diabetes]A J Scheen, L F Van GaalRevue Medicale De Liege|April 10, 2012
[Linagliptin (Trajenta): a selective DPP-4 inhibitor with limited renal elimination]A J Scheen, L F Van GaalRevue Medicale Suisse|September 24, 2009
[Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics]A Nyssen, V Legrand, A J ScheenRevue Medicale De Liege|April 24, 2010
[Sugar: results of a Belgian observational study on the use of sitagliptin in patients with type 2 diabetes]A J Scheen, L F Van GaalRevue Medicale De Liege|April 28, 2007
[Cardiometabolic effects of rimonabant in obese/overweight subjects with dyslipidaemia or type 2 diabetes]A J Scheen, L F Van GaalRevue Medicale De Liege|April 11, 2001
[Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy]J C Philips, L Weekers, A J ScheenRevue Medicale De Liege|April 16, 2003
[Islet cell transplantation: a step toward curing diabetes?]J C Philips, R Radermecker, A J ScheenDiabetes & Metabolism|October 28, 2011
Haemodynamic changes during a squat test, pulsatile stress and indices of cardiovascular autonomic neuropathy in patients with long-duration type 1 diabetesJ-C Philips, M Marchand, A J ScheenPageof 62